Yu Feng

1.1k total citations
52 papers, 858 citations indexed

About

Yu Feng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yu Feng has authored 52 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Yu Feng's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Yu Feng is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Yu Feng collaborates with scholars based in China, United States and Israel. Yu Feng's co-authors include Guangliang Jiang, L. Clifton Stephens, K. Kian Ang, Howard D. Thames, Roland Guttenberger, Yanfang Yang, Yue Gao, K.K. Ang, Roger E. Price and L. J. Peters and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yu Feng

49 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Feng China 15 264 215 150 142 126 52 858
Yasuhiro Kikuchi Japan 20 393 1.5× 196 0.9× 176 1.2× 169 1.2× 318 2.5× 84 1.1k
Julia Heß Germany 20 137 0.5× 181 0.8× 71 0.5× 121 0.9× 500 4.0× 43 1.0k
Yoko Hirabayashi Japan 15 166 0.6× 134 0.6× 86 0.6× 118 0.8× 331 2.6× 57 942
Jia‐Tao Zhang China 14 491 1.9× 422 2.0× 84 0.6× 72 0.5× 119 0.9× 77 903
Young Eun Choi South Korea 18 65 0.2× 197 0.9× 183 1.2× 105 0.7× 509 4.0× 39 930
Andrew R. Snyder United States 14 175 0.7× 206 1.0× 54 0.4× 294 2.1× 549 4.4× 18 903
Kaori Tsutsumi Japan 13 110 0.4× 103 0.5× 43 0.3× 97 0.7× 280 2.2× 33 733
Suping Guo China 20 213 0.8× 275 1.3× 139 0.9× 68 0.5× 498 4.0× 65 977
Jérôme Lacombe United States 16 111 0.4× 102 0.5× 94 0.6× 195 1.4× 255 2.0× 33 644
Gillian M. Ross United Kingdom 8 99 0.4× 405 1.9× 167 1.1× 112 0.8× 692 5.5× 8 1.2k

Countries citing papers authored by Yu Feng

Since Specialization
Citations

This map shows the geographic impact of Yu Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Feng more than expected).

Fields of papers citing papers by Yu Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Feng. The network helps show where Yu Feng may publish in the future.

Co-authorship network of co-authors of Yu Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Feng. A scholar is included among the top collaborators of Yu Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Feng. Yu Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yun, Jiatong Wang, Jiahui Lü, et al.. (2025). Effects of combined application of compound fertilizer and biochar on absorption and utilization of phosphorus by wheat. PeerJ. 13. e20308–e20308.
4.
Hua, Rong, Hong‐Fei Yao, Yu Feng, et al.. (2024). Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis. Cancer Letters. 603. 217213–217213. 5 indexed citations
5.
Wang, Jin, et al.. (2024). Aging-Related Gene-Based Prognostic Model for Lung Adenocarcinoma: Insights into Tumor Microenvironment and Therapeutic Implications. International Journal of Molecular Sciences. 25(24). 13572–13572. 1 indexed citations
6.
Liu, Xianfeng, et al.. (2024). Climate-driven changes in drought metrics across the Yellow River Basin based on Coupled Model Intercomparison Project Phase 6. Journal of Geographical Sciences. 34(9). 1841–1856. 2 indexed citations
7.
Feng, Yu, Yunxia Tao, Haizhu Chen, et al.. (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis. Thoracic Cancer. 14(25). 2536–2547. 15 indexed citations
8.
Zhu, Huijuan, et al.. (2023). 2188P First-line combination of toripalimab and chemotherapy in advanced thymic carcinoma: A prospective, single-arm, phase II trial. Annals of Oncology. 34. S1132–S1133. 4 indexed citations
10.
Tao, Yunxia, Yu Zhou, Le Tang, et al.. (2022). Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer: A systematic review and meta-analysis. Investigational New Drugs. 40(4). 831–840. 11 indexed citations
11.
Feng, Yu, Yutao Liu, Hongxia Zhang, et al.. (2021). The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer. Cancer Research and Treatment. 54(3). 753–766. 7 indexed citations
12.
Zhang, Shiming, et al.. (2020). Osmotic pump tablets with solid dispersions synergized by hydrophilic polymers and mesoporous silica improve in vitro/in vivo performance of cilostazol. International Journal of Pharmaceutics. 588. 119759–119759. 9 indexed citations
13.
Zhu, Ying, Yu Feng, Xiaoyu Yang, et al.. (2020). A CT-derived deep neural network predicts for programmed death ligand-1 expression status in advanced lung adenocarcinomas. Annals of Translational Medicine. 8(15). 930–930. 21 indexed citations
14.
Zhang, Yun, Yanfang Yang, Jun Ye, et al.. (2020). Construction of chlorogenic acid-containing liposomes with prolonged antitumor immunity based on T cell regulation. Science China Life Sciences. 64(7). 1097–1115. 30 indexed citations
15.
Qin, Shanshan, Hui Yu, Zhiguo Luo, et al.. (2019). Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study. Chinese Journal of Cancer Research. 31(2). 339–348. 8 indexed citations
16.
Shen, Feng, et al.. (2019). Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2. International Journal of Colorectal Disease. 34(6). 1095–1104. 5 indexed citations
17.
Feng, Yu, et al.. (2018). Early intradural microsurgery improves neurological recovery of acute spinal cord injury: A study of 87 cases. Journal of Neurorestoratology. 6(1). 152–157. 3 indexed citations
18.
Cho, Jong Ho, Yoon‐La Choi, Yu Feng, et al.. (2017). Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples. Clinical Lung Cancer. 18(6). e473–e479. 32 indexed citations
20.
Feng, Yu. (2013). Association between XRCC1 Arg399 Gln Polymorphisms in Non-small Cell Lung Cancer with Efficacy of Platinum-based Chemotherapy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026